Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF MARKETING OFFICER | August 30, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date August 30, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,843 |
Ending reported balance
After 2024-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-08-30 · Exercise / conversion · Acquired 1,109 · Balance 46,267 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-08-30 · Exercise / conversion · Acquired 1,404 · Balance 47,671 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2024-08-30 · Exercise / conversion · Acquired 3,255 · Balance 50,926 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2024-09-03 · Sale · Disposed 2,083 · Balance 48,843 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,658 |
Reported balance
After 2024-08-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-08-30 · Exercise / conversion · Disposed 1,109 · Balance 6,658 F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,808 |
Reported balance
After 2024-08-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-08-30 · Exercise / conversion · Disposed 1,404 · Balance 2,808 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,532 |
Reported balance
After 2024-08-30 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-08-30 · Exercise / conversion · Disposed 3,255 · Balance 19,532 F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2020 Filed Apr 20, 2020 16:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 93,597 | $169.63 | $15,876,859.11 |
DisclosureSEC source: 0001179110-20-004982 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,240 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 2, 2020. F2 · price: Represents the weighted average price of transactions ranging from $167.69 to $171.19. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 16:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 93,597 | $17.99 | $1,683,810.03 |
DisclosureSEC source: 0001179110-20-004982 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,402 Underlying: Common Stock · 3,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 11,103 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 Underlying: Common Stock · 4,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On February 26, 2020, the reporting person earned 14,434 performance stock units, vesting in three annual installments beginning on March 4, 2020. F4 · derivative.expiration_date: On February 26, 2020, the reporting person earned 14,434 performance stock units, vesting in three annual installments beginning on March 4, 2020. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 1,570 | $132.73 | $208,386.10 |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,240 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 2,314 | $132.73 | $307,137.22 |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,109 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003229 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 689 | $125.30 | $86,331.70 |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,612 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 5,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,422 Underlying: Common Stock · 5,422 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,169 Underlying: Common Stock · 3,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 1,145 | $124.32 | $142,346.40 |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,376 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-003099 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 14,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002592 · edgar.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,434 Underlying: Common stock · 14,434 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2019 financial results. F3 · derivative.exercise_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. F3 · derivative.expiration_date: The performance stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · derivative · entry 7 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,850 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F6 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 632 | $60.62 | $38,311.84 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,352 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 06, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 11,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,103 Underlying: Common Stock · 11,103 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,338 Underlying: Common Stock · 3,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 9,507 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 1,035 | $67.55 | $69,914.25 |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 18:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003462 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · derivative · entry 6 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock · 6,000 shares Expires 2026-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on January 4, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $17.99 | $0.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · derivative · entry 5 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Common Stock · 12,000 shares Expires 2026-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on January 4, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,000 | $75.32 | $451,920.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · nonDerivative · entry 4 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 20, 2018. F3 · price: Represents the weighted average price of transactions ranging from $75.00 to $75.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 12,000 | $74.52 | $894,240.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · nonDerivative · entry 3 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 20, 2018. F2 · price: Represents the weighted average price of transactions ranging from $74.00 to $75.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,000 | $17.99 | $107,940.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · nonDerivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2018 Filed Sep 25, 2018 10:55 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,000 | $17.99 | $215,880.00 |
DisclosureSEC source: 0001179110-18-011636 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-004290 · edgar.xml · derivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,775 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F2 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-004290 · edgar.xml · nonDerivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 19:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 9,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003543 · edgar.xml · derivative · entry 2 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,507 Underlying: Common Stock · 9,507 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 19:25 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 47,300 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-18-003543 · edgar.xml · derivative · entry 1 Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,300 Underlying: Common Stock · 47,300 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 1, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.